(Q37279934)

19 August 2017

1 reference

title

Clinical observations programme in SpA: disease parameters, treatment options and practical management issues (English)

1 reference

19 August 2017

3

Gust Verbruggen

1 reference

19 August 2017

Dirk Elewaut

1

1 reference

19 August 2017

Filip Van den Bosch

2

1 reference

19 August 2017

Filip de Keyser

4

1 reference

19 August 2017

Bert Vander Cruyssen

5

1 reference

19 August 2017

Herman Mielants

6

1 reference

19 August 2017

publication date

26 September 2008

1 reference

Rheumatology International

19 August 2017

published in

1 reference

19 August 2017

volume

29

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

239-250

1 reference

Update on spondyloarthropathies

19 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-008-0714-5

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

12 December 2020

HLA-B27-associated spondyloarthritis and enthesopathy in childhood: clinical, pathologic, and radiographic observations in 58 patients

1 reference

12 December 2020

Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations

1 reference

12 December 2020

A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis

1 reference

12 December 2020

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

1 reference

12 December 2020

Clinical features of acute anterior uveitis

1 reference

12 December 2020

Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.

1 reference

12 December 2020

Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome

1 reference

12 December 2020

Chondroprotective drugs in degenerative joint diseases

1 reference

12 December 2020

The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

1 reference

12 December 2020

The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy

1 reference

12 December 2020

Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements

1 reference

12 December 2020

Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease.

1 reference

12 December 2020

Characterisation of uveitis in patients with psoriatic arthritis

1 reference

12 December 2020

Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints

1 reference

12 December 2020

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

12 December 2020

Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

1 reference

12 December 2020

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

1 reference

12 December 2020

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease

1 reference

12 December 2020

HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility

1 reference

12 December 2020

Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms

1 reference

12 December 2020

The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Groupe Français d'Etude Génétique des Spondylarthropathies

1 reference

12 December 2020

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

12 December 2020

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

1 reference

12 December 2020

Cigarette Smoking and Appendectomy are Risk Factors for Extraintestinal Manifestations in Ulcerative Colitis

1 reference

12 December 2020

Current guidelines for the drug treatment of ankylosing spondylitis

1 reference

12 December 2020

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.

1 reference

12 December 2020

Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging

1 reference

12 December 2020

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

12 December 2020

Six months open label trial of leflunomide in active ankylosing spondylitis

1 reference

12 December 2020

Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.

1 reference

12 December 2020

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

1 reference

12 December 2020

Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C.

1 reference

12 December 2020

Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study

1 reference

12 December 2020

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

1 reference

12 December 2020

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial

1 reference

12 December 2020

Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel

1 reference

12 December 2020

Characterization of uveitis associated with spondyloarthritis

1 reference

12 December 2020

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

1 reference

12 December 2020

Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest

1 reference

12 December 2020

Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage

1 reference

12 December 2020

Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

1 reference

12 December 2020

Open label trial of anakinra in active ankylosing spondylitis over 24 weeks

1 reference

12 December 2020

Homeostasis of the extracellular matrix of normal and osteoarthritic human articular cartilage chondrocytes in vitro.

1 reference

12 December 2020

Concepts and epidemiology of spondyloarthritis

1 reference

12 December 2020

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

1 reference

12 December 2020

The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.

1 reference

12 December 2020

Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex

1 reference

12 December 2020

HL-A 27 and acute anterior uveitis

1 reference

12 December 2020

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis

1 reference

12 December 2020

Insulin‐like growth factor 1–induced interleukin‐1 receptor II overrides the activity of interleukin‐1 and controls the homeostasis of the extracellular matrix of cartilage

1 reference

12 December 2020

Impact of sex on inheritance of ankylosing spondylitis: a cohort study

1 reference

12 December 2020

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

12 December 2020

Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

12 December 2020

Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci

1 reference

12 December 2020

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

1 reference

12 December 2020

Osteochondral repair in synovial joints

1 reference

12 December 2020

Lack of association of HLA B27 with radiographic sacroiliitis in inflammatory bowel disease

1 reference

12 December 2020

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

12 December 2020

Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy

1 reference

12 December 2020

Susceptibility to ankylosing spondylitis in twins the role of genes, HLA, and the environment

1 reference

12 December 2020

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial

1 reference

12 December 2020

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

1 reference

12 December 2020

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

12 December 2020

Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression

1 reference

12 December 2020

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

1 reference

12 December 2020

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

1 reference

12 December 2020

Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents

1 reference

12 December 2020

NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria

1 reference

12 December 2020

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

1 reference

12 December 2020

The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.

1 reference

12 December 2020

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

1 reference

12 December 2020

Conventional treatments for ankylosing spondylitis.

1 reference

12 December 2020

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

1 reference

12 December 2020

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

12 December 2020

10.1007/S00296-008-0714-5

Identifiers

DOI

1 reference

19 August 2017

1 reference